Cargando…
Assessment of the immune landscapes of advanced ovarian cancer in an optimized in vivo model
BACKGROUND: Ovarian cancer (OC) is typically diagnosed late, associated with high rates of metastasis and the onset of ascites during late stage disease. Understanding the tumor microenvironment and how it impacts the efficacy of current treatments, including immunotherapies, needs effective in vivo...
Autores principales: | Pisano, Simone, Lenna, Stefania, Healey, Gareth D., Izardi, Fereshteh, Meeks, Lucille, Jimenez, Yajaira S., Velazquez, Oscar S, Gonzalez, Deyarina, Conlan, Robert Steven, Corradetti, Bruna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506632/ https://www.ncbi.nlm.nih.gov/pubmed/34709744 http://dx.doi.org/10.1002/ctm2.551 |
Ejemplares similares
-
Immune (Cell) Derived Exosome Mimetics (IDEM) as a Treatment for Ovarian Cancer
por: Pisano, Simone, et al.
Publicado: (2020) -
Editorial: Exosomes as Therapeutic Systems
por: Corradetti, Bruna, et al.
Publicado: (2021) -
A RAGE-Targeted Antibody-Drug Conjugate: Surface Plasmon Resonance as a Platform for Accelerating Effective ADC Design and Development
por: Healey, Gareth D., et al.
Publicado: (2019) -
Liquid crystal delivery of ciprofloxacin to treat infections of the female reproductive tract
por: Pisano, Simone, et al.
Publicado: (2019) -
Mechanomimetic 3D Scaffolds as a Humanized In Vitro Model for Ovarian Cancer
por: Paradiso, Francesca, et al.
Publicado: (2022)